Data

A double-blinded placebo-controlled parallel design trial to determine whether inhibiting intestinal sweet taste sensing improves glycaemic responses in patients with type 2 diabetes

Health Data Australia Contributor Records
Young, Dr Richard ; Young, Richard ; Young, Richard
Viewed: [[ro.stat.viewed]] Cited: [[ro.stat.cited]] Accessed: [[ro.stat.accessed]]
ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Adc&rfr_id=info%3Asid%2FANDS&rft_id=info:doi10.58138/T1DG-3774&rft.title=A double-blinded placebo-controlled parallel design trial to determine whether inhibiting intestinal sweet taste sensing improves glycaemic responses in patients with type 2 diabetes, Blocking intestinal sweet taste for glycaemic benefits in type 2 diabetes&rft.identifier=http://doi.org/10.58138/T1DG-3774&rft.publisher=South Australian Health and Medical Research Institute&rft.description=Intestinal sweet taste receptors (STRs) sense all sweet stimuli to coordinate the absorption and metabolism of glucose. A defect in intestinal STRs in patients with type 2 diabetes (T2D), as well as supplementation of low-calorie sweeteners in non-diabetic subjects, both accelerate glucose absorption and worsen glycaemic control. This is a double-blinded placebo-controlled parallel design trial to determine whether inhibiting intestinal sweet taste sensing improves glycaemic responses in patients with type 2 diabetes, by blocking intestinal STRs in patients with T2D.HeSANDA 1.0.0&rft.creator=Young, Dr Richard &rft.creator=Young, Richard &rft.creator=Young, Richard &rft.date=2027&rft.relation=https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12621000981820&rft.coverage=South Australia&rft_subject=FOS: Medical and health sciences&rft.type=dataset&rft.language=English Access data via landing page
Cite Saved to MyRDA Save to MyRDA

Full description

Intestinal sweet taste receptors (STRs) sense all sweet stimuli to coordinate the absorption and metabolism of glucose. A defect in intestinal STRs in patients with type 2 diabetes (T2D), as well as supplementation of low-calorie sweeteners in non-diabetic subjects, both accelerate glucose absorption and worsen glycaemic control. This is a double-blinded placebo-controlled parallel design trial to determine whether inhibiting intestinal sweet taste sensing improves glycaemic responses in patients with type 2 diabetes, by blocking intestinal STRs in patients with T2D.
HeSANDA 1.0.0

Collected:

Data time period: 2021 2024

This dataset is part of a larger collection

Click to explore relationships graph
Help

Related Publications

Related Organisations

Related People

Spatial Coverage And Location

text: South Australia

Subjects
FOS: Medical and health sciences |

User Contributed Tags    

Login to tag this record with meaningful keywords to make it easier to discover

Other Information
Young, Richard

ORCID : https://orcid.org/0000-0001-5116-4951

Diabetes Australia

Crossref Funder ID : https://doi.org/10.13039/501100000971

Diabetes Australia

Crossref Funder ID : https://doi.org/10.13039/501100000971

Identifiers